Pro-Dex, Inc. (PDEX) vs Exagen Inc. (XGN)
A side-by-side comparison of Pro-Dex, Inc. and Exagen Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
PDEX
Pro-Dex, Inc.
$65.35HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT
XGN
Exagen Inc.
$8.30HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — PDEX vs XGN
growth of $100 · dividends reinvested · last 7yPDEX +325.0% (+23.0%/yr)XGN -54.5% (-10.6%/yr)PDEX compounded faster over this window
Log scale — wide-divergence pair
PDEX XGN
PDEX vs XGN: by the numbers
- •PDEX is the larger company ($209M vs $200M market cap).
- •PDEX is profitable (17.62% net margin) while XGN runs a net loss (-26.61%).
- •PDEX grew revenue faster over the past five years (15.32% vs 8.73% CAGR).
Metrics side by side
Valuation
| Metric | PDEX | XGN |
|---|---|---|
| P/E ratio | 15.86 | N/A |
| Forward P/E | 21.15 | N/A |
| PEG ratio | 0.54 | N/A |
| P/S ratio | 2.69 | 2.82 |
| P/B ratio | 4.38 | 16.41 |
| EV / EBITDA | 15.19 | N/A |
| FCF yield | 3.30% | N/A |
Profitability
| Metric | PDEX | XGN |
|---|---|---|
| Gross margin | 31.38% | 58.64% |
| Operating margin | 16.75% | -18.58% |
| Net margin | 17.62% | -26.61% |
| ROE | 28.68% | -154.90% |
| ROIC | 14.99% | -33.88% |
Growth (annualized)
| Metric | PDEX | XGN |
|---|---|---|
| Revenue CAGR (5Y) | 15.32% | 8.73% |
| EPS CAGR (5Y) | 29.38% | N/A |
| Total return CAGR (5Y) | 20.45% | -8.40% |
Frequently asked
- Which has grown faster, PDEX or XGN?
- Over the past five years, PDEX grew revenue faster — PDEX at a 15.32% CAGR versus XGN at 8.73%.
- Is PDEX or XGN more profitable?
- PDEX runs the higher net margin — PDEX at 17.62% versus XGN at -26.61%.
- How have PDEX and XGN total returns compared?
- Over the past 5 years, PDEX delivered 20.45% and XGN delivered -8.40% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Pro-Dex P/E ratioPro-Dex ROEExagen ROEPro-Dex operating marginExagen operating marginPro-Dex revenue growthExagen revenue growthPro-Dex free cash flowExagen free cash flow
Pro-Dex & Exagen appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.